宏潤建設(002062.SZ):中標1.21億元邱隘鎮前殷區塊二期配套道路工程II標施工項目
格隆匯 2 月 2日丨宏潤建設(002062.SZ)公佈,公司於近日收到寧波市鄞州區公共資源交易平台施工招標中標通知書,邱隘鎮前殷區塊二期配套道路工程II標施工項目由公司中標承建,工程中標價約1.21億元。
該工程的中標有利於進一步提升公司參與相關業務的市場競爭力和市場份額。該工程中標價佔公司2019年度營業收入的1.01%,對公司2021年度及未來財務狀況和經營成果無重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.